Submitted by elizabethwu1 on Thu, 01/21/2016 - 3:20pm NCT02565511 Umibecestat United States Sunday, November 1, 2015 – Monday, September 30, 2024 1 340 Phase 2/3 Alzheimer's Disease Thursday, January 21, 2016 Novartis Pharmaceuticals Corporation Comments No Available Comments Make a Comment To make a comment you must login or register.
Submitted by elizabethwu1 on
Submitted by elizabethwu1 on
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.